Workshop on the epidemiology of the ATM gene: Impact on breast cancer risk and treatment, present status and future, focus, Lillehammer, Norway, 29 June 2002

Breast Cancer Research

Volumn 4, Issue 6, 2002, Pages 249-252

  Bernstein, Jonine L ^a   Seminara, Daniela ^b   Børresen Dale, Anne Lise ^c  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^b NATIONAL CANCER INSTITUTE   (United States)

^c OSLO UNIVERSITY HOSPITAL   (Norway)

Author keywords

ATM gene; Breast cancer risk; Heterozygote; Radiation

Indexed keywords

ATM PROTEIN; BRCA1 PROTEIN; BRCA2 PROTEIN; PROTEIN P53;

BIOSTATISTICS; BREAST CANCER; BREAST CARCINOGENESIS; CANCER CENTER; CANCER RISK; CLINICAL GENETICS; CONFERENCE PAPER; EXPERIMENTAL DESIGN; FEMALE; GENE FUNCTION; GENE MUTATION; GENETIC ANALYSIS; GENETIC EPIDEMIOLOGY; GENETIC SCREENING; HETEROZYGOSITY; HETEROZYGOTE; HUMAN; IN VITRO STUDY; INTERNAL MEDICINE; MEDICAL SPECIALIST; MOLECULAR GENETICS; PATHOLOGY; RADIATION EXPOSURE; RADIATION PHYSICS; RADIOBIOLOGY; RADIOSENSITIVITY; WORKSHOP;

BREAST NEOPLASMS; CELL CYCLE PROTEINS; DNA-BINDING PROTEINS; FEMALE; HUMANS; MUTATION; PROTEIN-SERINE-THREONINE KINASES; RADIATION TOLERANCE; RISK; TUMOR SUPPRESSOR PROTEINS;

EID: 0036440939     PISSN: 14655411     EISSN: None     Source Type: Journal    
DOI: 10.1186/bcr551     Document Type: Conference Paper

References (14)

1. Gatti RA, Tward A, Concannon P: Cancer risk in ATM heterozygotes: a model of phenotypic and mechanistic differences between missense and truncating mutations. Mol Genet Metab 1999, 68:419-423.
2. Pippard E, Hall A, Barker D, Bridges B: Cancer in homozygotes and heterozygotes of ataxia-telangiectasia and xeroderma pigmentosum in Britain. Cancer Res 1988, 48:2929-2932.
3. Borresen A, Andersen T, Tretli S, Heilberg A, Moller P: Breast cancer and other cancers in Norwegian families with ataxiate-langiectasia. Genes Chromosomes Cancer 1990, 2:339-340.
4. Swift M, Morrell D, Massey R, Chase C: Incidence of cancer in 161 families affected by ataxia-telangiectasia. N Engl J Med 1991, 325:1831-1836.
5. Easton D: Cancer risks in A-T heterozygotes. Int J Rad Biol 1994, 66:S177-S182.
6. Athma P, Rappaport R, Swift M: Molecular genotyping shows that ataxia-telangiectasia heterozygotes are predisposed to breast cancer. Cancer Genet Cytogenet 1996, 92:130-134.
7. Janin N, Andrieu N, Ossaian K, Lauge A, Croquette M, Griscelli C, Debre M, Bressac-de-Paillertes B, Aurias A, Stoppa-Lyonnet D: Breast cancer risk in ataxia telangiectasia (AT) heterozygotes: haplotype study in French AT families. Br J Cancer 1999, 80: 1042-1045.
8. Inskip H, Kinlen L, Taylor A, Woods C, Arlett C: Risk of breast cancer and other cancers in heterozygotes for ataxia telangiectasia. Br J Cancer 1999, 79:1304-1307.
9. Shafman TD, Levitz S, Nixon AJ, Gibans LA, Nichols KE, Bell DW, Ishioka C, Isselbacher KJ, Gelman R, Garber J, Harris JR, Haber DA: Prevalence of germline truncating mutations in ATM in women with a second breast cancer after radiation therapy for a contralateral tumor. Genes Chromosomes Cancer 2000, 27:124-129.
10. Teraoka SN, Malone KE, Doody DR, Suter NM, Ostrander EA, Daling JR, Concannon P: Increased frequency of ATM mutations in breast carcinoma patients with early onset disease and positive family history. Cancer 2001, 92:479-487.
11. Olsen JH, Hahnemann JM, Borresen-Dale AL, Brondum-Nielsen K, Hammarstrom L, Kleinerman R, Kaariainen H, Lonnqvist T, Sankila R, Seersholm N, Tretli S, Yuen J, Boice JD Jr, Tucker M: Cancer in patients with ataxia-telangiectasia and in their relatives in the nordic countries. J Natl Cancer Inst 2001, 93:121-127.
12. Chenevix-Trench G, Spurdle AB, Gatei M, Kelly H, Marsh A, Chen X, Donn K, Cummings M, Nyholt D, Jenkins MA, Scott C, Pupo GM, Dork T, Bendix R, Kirk J, Tucker K, McCredie MR, Hooper JL, Sambrook J, Mann GJ, Khanna KK: Dominant negative ATM mutations in breast cancer families. J Natl Cancer Inst 2002, 94:205-215.
13. Angele S, Treilleux I, Taniere P, Martel-Planche G, Vuillaume M, Bailly C, Bremond A, Montesano R, Hall J: Abnormal expression of the ATM and TP53 genes in sporadic breast carcinomas. Clin Cancer Res 2000, 6:3536-3544.
14. Kairouz R, Clarke RA, Marr PJ, Watters D, Lavin MF, Kearsley JH, Lee CS: ATM protein synthesis patterns in sporadic breast cancer. Mol Pathol 1999; 52:252-256.